Statin Therapy for LDL-C Reduction

Introduction to Statin Dosage

The American College of Cardiology recommends rosuvastatin 20mg as a high-intensity statin therapy, capable of lowering LDL-C by ≥50% 1
Rosuvastatin 40mg provides approximately 8% greater LDL-C reduction compared to rosuvastatin 20mg, with 55% vs 63% reduction from baseline respectively, but this additional benefit must be weighed against potentially increased risk of adverse effects 1

The American Heart Association and American College of Cardiology guideline notes that the magnitude of percent LDL-C reduction achieved determines clinical benefit, with a 1% reduction in LDL-C giving approximately a 1% reduction in ASCVD risk 1
The American College of Cardiology recommends that the choice between rosuvastatin 20mg and 40mg should be guided by the patient's ASCVD risk level, with rosuvastatin 40mg preferred for very high-risk patients and rosuvastatin 20mg sufficient for primary prevention in moderate-risk patients 2
The European Heart Journal suggests that for very high-risk patients with established ASCVD who need maximum LDL-C reduction, rosuvastatin 40mg may be preferred 3

The American College of Cardiology recommends that if the goal is ≥50% reduction in LDL-C, rosuvastatin 20mg is usually adequate, but for more aggressive targets (<70 mg/dL or <55 mg/dL), the 40mg dose may be needed 1
The American Diabetes Association guidelines note that if patients cannot tolerate the intended intensity of statin, the maximally tolerated dose should be used 5
The European Heart Journal suggests that if the 40mg dose is not tolerated, combining rosuvastatin 20mg with ezetimibe may be more effective than uptitration and better tolerated 6

Start with rosuvastatin 20mg if the patient requires high-intensity statin therapy, has a moderate ASCVD risk, and an LDL-C reduction goal of approximately 50% 2
Consider rosuvastatin 40mg if the patient has very high ASCVD risk, has not achieved LDL-C goal on 20mg, or would benefit from an additional 8% LDL-C reduction 3
Consider rosuvastatin 20mg plus ezetimibe instead of uptitration to 40mg if there are concerns about tolerability with higher statin dose, need for >55% LDL-C reduction, or history of partial statin intolerance 6